M
MIRA
Mira Pharma
0.7455
+0.0425+6.05%After Hours: 0.7203 -0.0252 -3.38%18:36 10/09 EDT
OPEN/PREV CLOSE0.7200/0.7030
TODAY RANGE0.7030-0.7498
VOL52.43K
MARKET CAP31.33M
52 WEEK RANGE0.6000-2.450
AVG VOL (3M)585.53K
% TURNOVER0.11%
TURNOVER--
P/E (TTM)-0.5401
% RANGE6.66%
EPS(TTM)-1.3802
P/E(FORWARD)-6.2125
P/B3.839
BVPS0.1942
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP21.75M
SHARES OUTSTANDING42.02M
NEXT EARNINGS11/11-11/16
FREE FLOAT29.17M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
NASDAQ·10/03 01:48
MIRA Pharmaceuticals Consensus Price Target Increased by 16.67% to $3.57
Benzinga·09/21 21:06
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga·09/18 21:06
12 Health Care Stocks Moving In Friday's After-Market Session
Dow Jones·09/17 15:19
MIRA Pharmaceuticals Price Target Announced at $3.50/Share by Maxim Group
TipRanks·09/17 12:58
MIRA advances Ketamir-2 Phase 2a neuropathy program
TipRanks·09/17 12:45
Mira advances Ketamir-2 to chemotherapy-induced peripheral neuropathy
TipRanks·09/03 14:05
Psychedelic: Clearmind initiates Phase IIa of CMND-100 trial
Seeking Alpha·09/02 14:15
Short Interest Alert: Most and least shorted sub-$2B healthcare stocks in Aug 2026
Benzinga·09/01 17:12
Why Is MIRA Pharmaceuticals Stock Gaining Tuesday?
Benzinga·09/01 17:07
12 Health Care Stocks Moving In Tuesday's Intraday Session
TipRanks·09/01 12:27
MIRA-55 toxicology results advance non-opioid pain program
TipRanks·09/01 12:20
Mira Pharmaceuticals announces results from MIRA-55 studies